Corevitas Inflammatory Bowel Disease (IBD) Registry

Go Back to All Clinical Trials

Corevitas Inflammatory Bowel Disease (IBD) Registry

Brief description of study

The primary objective for this registry is to prospectively study the natural history of IBD, the prevalence and incidence of comorbidities, and targeted adverse events, as well as the utilization patterns and the comparative effectiveness and comparative safety of approved IBD treatments.The Corrona IBD Registry is a prospective, non-interventional, research study for patients with IBD under the care of a certified gastroenterologist. Target enrollment is approximately 1,000 patients in the first year with no defined upper limit on enrollment after year one. Approximately 100 clinical gastroenterology clinics in the U.S. will be recruited to participate.

Clinical Study Identifier: s17-01623

Principal Investigator: David P Hudesman.

Other Investigators: Elie S Al Kazzi, Bradley M. Morganstern, Shannon Chang.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies